We narrowed to 17,881 results for: puromycin
-
Plasmid#107505PurposeExpresses eGFP, puromycin resistantDepositorInserteGFP
UseLentiviralExpressionMammalianPromoterCMVAvailable sinceNov. 7, 2018AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pvPE-V4-Puro
Plasmid#240290PurposeEncodes fourth generation porcine endogenous retrovirus-derived prime editing (pvPE) system with puromycin resistance gene into mammalian cells for gene editing.DepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertpvPE-V4-Puro
UseCRISPRTagsSV40 NLS and c-Myc NLSExpressionMammalianPromoterCMVAvailable sinceOct. 8, 2025AvailabilityAcademic Institutions and Nonprofits only -
pMSCV-FLAG-2xSTREP-CCND3-Puro
Plasmid#172619PurposeRetroviral vector for the constitutive expression of FLAG-2xSTREP-tagged cyclin D3 and a puromycin resistance marker in mammalian cellsDepositorAvailable sinceAug. 20, 2021AvailabilityAcademic Institutions and Nonprofits only -
pLenti_P2A_Puro
Plasmid#211364PurposeLentiviral expression vector for an insert of interest linked to a P2A-T2A puromycin sequence. Produces virus very efficiently. Can also be used for regular transfectionsDepositorTypeEmpty backboneUseLentiviralExpressionMammalianAvailable sinceJan. 18, 2024AvailabilityAcademic Institutions and Nonprofits onlyCited by -
pLV[TetOn]-Puro-TRE3G>mNeurog2
Plasmid#198754PurposeVector encodes the gene for murine neurogenin-2 under control of a Tet-controlled promoter and the puromycin resistance gene under control of a constitutive PGK promoterDepositorAvailable sinceJuly 31, 2023AvailabilityAcademic Institutions and Nonprofits only -
pLex307-UCOE-SFFV-puroR-MCP-MLLx3-HSF1
Plasmid#218558PurposeEncodes SFFV promoter-driven MCP-MLLx3-HSF1 with an N-terminal bipartite SV40 NLS, along with puromycin resistanceDepositorInsertMCP-MLLx3-HSF1
UseLentiviralTagsSV40NLSExpressionMammalianMutationCas9 mutations to make dCas9=D10A+D839A+H840A+N86…Available sinceAug. 13, 2025AvailabilityAcademic Institutions and Nonprofits only -
PAC_E83_LOV_eGFP
Plasmid#231574PurposeThis plasmid mediates puromycin resistance in the dark, resulting in puro mediated cell death upon illumination with blue lightDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertPAC-P2A-GFP carrying an insertion of AsLOV2 behind E83
ExpressionMammalianAvailable sinceFeb. 7, 2025AvailabilityAcademic Institutions and Nonprofits onlyCited by -
PEA1-Nuclease-Puro HEK3 CTT ins
Plasmid#171995PurposeDelivers all prime editing nuclease components targeting the HEK3 gene for a CTT inserrtion, in a single, puromycin selectable plasmidDepositorHas service50 µg Transfection-Ready DNA and 100 µg Transfection-Ready DNAInsertHEK3 CTT insertion pegRNA and CbH-Cas9-RT-T2A-Puro, hU6-pegRNA HEK3 CTT ins, hU6-sgRNA sham
ExpressionMammalianPromoterCMV for Cas9, U6 for gRNAsAvailable sinceSept. 6, 2021AvailabilityAcademic Institutions and Nonprofits only -
pHAGE-TRE-DEST-PGK-puro
Plasmid#259775PurposeGateway-compatible destination vector for doxycycline-inducible ORF expression and puromycin resistanceDepositorTypeEmpty backboneUseGateway Cloning and LentiviralExpressionMammalianPromoterTet Response Element (TRE)Available sinceAug. 19, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5
Plasmid#247691PurposeConstitutive expression of SARS-CoV-2 nsp5 under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease
UseLentiviralExpressionMammalianPromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-C145A
Plasmid#247692PurposeConstitutive expression of SARS-CoV-2 nsp5 with C145A mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with C145A
UseLentiviralExpressionMammalianMutationC145APromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-T21I
Plasmid#247693PurposeConstitutive expression of SARS-CoV-2 nsp5 with a T21I mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with T21I
UseLentiviralExpressionMammalianMutationT21IPromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-L50F
Plasmid#247694PurposeConstitutive expression of SARS-CoV-2 nsp5 with a L50F mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with L50F
UseLentiviralExpressionMammalianMutationL50FPromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-E166V
Plasmid#247695PurposeConstitutive expression of SARS-CoV-2 nsp5 with a E166V mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with E166V
UseLentiviralExpressionMammalianMutationE166VPromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-E166A
Plasmid#247696PurposeConstitutive expression of SARS-CoV-2 nsp5 with a E166A mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with E166A
UseLentiviralExpressionMammalianMutationE166APromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-S144A
Plasmid#247697PurposeConstitutive expression of SARS-CoV-2 nsp5 with a S144A mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with S144A
UseLentiviralExpressionMammalianMutationS144APromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX307-puro-SARS-CoV-2-nsp5-T304I
Plasmid#247698PurposeConstitutive expression of SARS-CoV-2 nsp5 with a T304I mutation under EF1-alpha promoter with puromycin resistance.DepositorInsertSARS-CoV-2 3CL protease with T304I
UseLentiviralExpressionMammalianMutationT304IPromoterEF1aAvailable sinceJuly 20, 2026AvailabilityAcademic Institutions and Nonprofits only -
pLEX305-pGK-N-dTAG-HA-PSMF1(1-230_R231X)_PuroR
Plasmid#251198PurposeLentiviral expression in Mammalian cells of N-terminally dTAG and HA-tagged PSMF1 containing point mutation R231X leading to the truncation encoding residues 1-230 and selection with PuromycinDepositorPublicationInsertPSMF1 (PSMF1 Human)
UseLentiviralTagsdTAG(FKBP12F36V)-HAExpressionMammalianMutationC-terminal truncation, encoding residues 1-230Available sinceJune 2, 2026AvailabilityAcademic Institutions and Nonprofits only -
pHAGE-N-FLAG-HA-FBXO7(169-522)-IRES-PuroR
Plasmid#251188PurposeLentiviral expression in Mammalian cells of N-terminally FLAG and HA-tagged FBXO7 containing PD mutation R498X, a truncation encoding residues 1-497 and selection with PuromycinDepositorPublicationInsertFBXO7 (FBXO7 Human)
UseLentiviralTagsFLAG-HAExpressionMammalianMutationN-terminal truncation, residues 169-522Available sinceJune 2, 2026AvailabilityAcademic Institutions and Nonprofits only -
pHAGE-N-FLAG-HA-FBXO7(169-406)-IRES-PuroR
Plasmid#251189PurposeLentiviral expression in Mammalian cells of N-terminally FLAG and HA-tagged FBXO7 containing PD mutation R498X, a truncation encoding residues 1-497 and selection with PuromycinDepositorPublicationInsertFBXO7 (FBXO7 Human)
UseLentiviralTagsFLAG-HAExpressionMammalianMutationN-terminal truncation and C-terminal truncation, …Available sinceJune 2, 2026AvailabilityAcademic Institutions and Nonprofits only